Skip to content

Nearly a million have started taking PrEP worldwide – only a third of UNAIDS’ 2020 target

Kate Segal presenting to HIVR4P 2021.

New ethical obligations for researchers in places where existing HIV prevention services are inadequate

Peter Godfrey-Faussett (top right) presenting at HIVR4P 2021.

Once-a-month PrEP pill easily passes its first big test

Professor Sharon Hillier at HIVR4P

A triumph for injectable PrEP, but a sobering result for oral PrEP

Professor Sinead Delany-Moretlwe presenting HPTN 084's study design

Antibody-based PrEP did not stop most types of HIV – but is still hailed as a ‘game changer’

Professor Larry Corey, principal researcher of the AMP studies, speaking at HIVR4P

European PrEP programmes face two big issues: how to get more people coming forward, and how to serve them if they do

Slide from the EACS Standard of Care meeting online workshop.

Middle-aged people with HIV and no hepatitis co-infection have a twofold increase in the risk of liver fibrosis

Shutterstock Studios

Big fall in HIV cases in Scotland after roll-out of PrEP

Marc Bruxelle/Shutterstock.com

Living with HIV associated with a fivefold increase in the risk of insomnia

Domizia Salusest | www.domiziasalusest.com